Abstract
] i at neurotransmitter release sites, 47 thereby bypassing anesthetic effects on channels and receptors allowing anesthetic effects on the 48 neurotransmitter release machinery to be examined in isolation. Three different PC12 cell lines, that 49 had the expression of different release machinery proteins stably suppressed by RNA interference, 50 were used in these studies. Interestingly, there was still significant neurotransmitter release when these 51 knockdown PC12 cells were stimulated. We have previously shown that etomidate, isoflurane and 52 propofol all inhibited the neurotransmitter release machinery in wild-type PC12 cells. In the current 53 study, we show that knocking-down synaptotagmin I completely prevented etomidate from inhibiting 54 neurotransmitter release. Synaptotagmin I knockdown also diminished the inhibition produced by 55 propofol and isoflurane, but the magnitude of the effect was not as large. Knockdown of SNAP-25 and 56 SNAP-23 expression also changed the ability of these three anesthetics to inhibit neurotransmitter 57 release. Our results suggest that general anesthetics inhibit the neurotransmitter release machinery by 58 interacting with multiple SNARE and SNARE-associated proteins.
Introduction

63
It is generally accepted that most general anesthetics facilitate GABA A receptor activity thereby 64 enhancing inhibitory synaptic transmission and that this alteration in GABA A receptor activity is an 65 important component of anesthesia. This is especially true for intravenous general anesthetics where 66 anesthesia is thought to be produced primarily through the facilitation of GABA A Westphalen & Hemmings, 2003 . 71 We have previously shown that the commonly used inhalational anesthetic, isoflurane, dose- that general anesthetics may target SNARE or SNARE-associated proteins, but that different 85 anesthetics may target different proteins. The goal of the current study is to examine the possible role 86 of other SNARE and SNARE-associated proteins in anesthesia more closely. 87 To prevent actions of anesthetics on channels or receptors from altering neurotransmitter 88 release, we use an experimental paradigms that keeps membrane potential constant, but which allows 
Materials and Methods
101
Ethical Information: All of the experiments outlined in this manuscript were carried out in PC12 cells.
102
No approval is required for these cells.
104
PC12 cell culture. PC12 cells were grown on collagen-coated 10 cm Petri dishes in culture medium 105 that consisted of RPMI-1640, 10% heat-inactivated horse serum, 5% fetal bovine serum, 2 mM 106 glutamine, and 10 µg/ml gentamicin in a humidified 7% CO 2 incubator at 37ºC. Culture medium was 107 replaced every other day and cells were passaged once per week. Cells were replated on poly-lysine 108 coated glass coverslips 24-48 hours prior to recording. After ~8 weeks in culture, cells were discarded 109 and previously frozen stocks were thawed and then kept in culture. defrosting an aliquot of cells, it typically took 2-3 weeks for the cultures to recover fully from freeze.
123
After cultures are kept in the incubator for several months, the cells stop secreting even with strong 124 stimuli. Thus there could be significant cell-to-cell variation in experiments performed on different 125 days. Cell-to-cell variation in experiments done on the same day using the same cultures was modest. 126 Thus, for each recording for an experimental group, a control cell was added on the same day at about 127 the same time. Without a matching control the experiment was not used. Cells that exhibited no 128 neurotransmitter release following stimulation, a relatively rare occurrence, were removed from the 129 data set. A student's t-test was used to assess differences between populations of cells. Fig 3A) as were half-times ( Fig. 3B ) and the number of molecules released per event (Fig. 3C ).
209
The only difference observed in our study was the number of events per stimulus was significantly had almost no effect on neurotransmitter release in synaptotagmin I knockdown PC12 cells (Fig. 7A wild-type PC12 cells (Fig. 8A) . In contrast, the responses to propofol and to etomidate were diminished 279 by the knockdown of SNAP-25. Figure 8B shows that propofol (5 μM) reduced the amount of 280 neurotransmitter release by ~27%. This response, about half that observed in wild-type PC12 cells, was 281 not significant (p=0.09, n=31). Etomidate (40 μm) reduced neurotransmitter release by ~8% (Fig. 8C,   282 p=0.73, n=25), a response only about one seventh that observed in wild-type PC12 cells. Thus, 283 knockdown of SNAP-25 expression reduced the inhibitory effect of propofol and almost completely 284 eliminated the response to etomidate, but did not change the inhibition produced by isoflurane. reduced by >60%. We were never able to achieve complete knockdown of both proteins; some SNAP- (Fig. 9A) . In contrast, the response to propofol was almost exactly 297 the same as that observed in wild-type PC12 cells; 5 μM propofol reduced the number of amperometric 298 events by ~51% (Fig. 7B, p=0.01, n=30 ). This result was surprising given that SNAP-25 suppression was not significant (Fig. 9C, p=0.39, n=18) . Thus, suppressing both SNAP-25 and SNAP-23 305 expression had a large effect on the response to isoflurane, no effect on propofol and completely 306 eliminated the response to etomidate. Fig. 1 ) was achieved. In this cell line we also observed differential effects on anesthetic 395 actions. There appeared to be little or no effect on the efficacy of propofol to inhibit neurotransmitter 
